induwara.lk
Opinionaistartupsdata-strategy

Outer Biosciences: the lab is the moat, not the model

Outer Biosciences keeps human skin alive for a month so its AI has data nobody else owns. For small teams the lesson is blunt: the moat is the measurement loop.

Induwara Ashinsana5 min read
Michael Polansky in a professional headshot portrait, image credited to Outer Biosciences
Image: TechCrunch

Outer Biosciences, the AI startup Michael Polansky has been building quietly since 2022, trains its models on human skin that is still alive. TechCrunch published the story on 21 August 2026, and most of the coverage will be about the celebrity board seat.

Skip that. The number worth staring at is this: a 19-person company raised about $23 million and spent most of it on plumbing, not on machine learning. Then its output rate jumped roughly tenfold. Nobody in the story claims a better model.


🔍 The model was never the bottleneck

Outer's own timeline splits cleanly into two eras, and the split tells you exactly what was holding them back.

Phase What the model learned from Output rate
Early era Published scientific literature 2 leads across ~18 months
Now Closed loop on living tissue ~1 candidate every 6 weeks

Same company. Same chemistry problem. Same broad category of model. The only thing that changed is where the training signal came from.

Literature mining is the version of this problem that anyone with an API key can attempt. That is precisely why it produced two leads in a year and a half. You are competing against everyone else reading the same papers, and the papers only contain what somebody already chose to publish.

Key takeaway: When your input data is public, your model output is a commodity. Outer's advantage is not the architecture. It is that they built a machine that produces observations nobody else has.


🧪 Skin that survives a month is the actual product

The technical claim underneath everything: Outer sources human skin from surgery through vetted biobanks with IRB oversight, and keeps it viable for up to one month. The stated industry norm is days. Chief scientist Kyung-Jin Jang leads that work, and the company says the tissue holds its day-zero architecture and molecular programs through month one.

That month is not a vanity metric. It changes which questions you are allowed to ask:

  • Days of viability measures irritation, acute toxicity, immediate response. Fast effects only.
  • Weeks of viability measures the slow stuff. Anything that takes time to show up was previously invisible to the assay.
  • A month lets the loop close repeatedly on the same tissue rather than resetting to a fresh sample with fresh variance.

The loop itself is simple to describe: the model proposes chemicals worth testing, the tissue tests them, the results go back into the model. That is a textbook data flywheel. What is hard, expensive, and worth $23 million is the middle step — the part that turns a prediction into a measurement.


🌐 The Sri Lankan version of this is not tissue

This is where the story gets useful, and it is not the obvious "start a biotech" reading.

You are not going to out-model Anthropic, OpenAI, or Google. That race is settled by capital you do not have. But the Outer story says the advantage never lived in the model. It lived in owning a measurement loop in a domain nobody had bothered to instrument.

Sri Lanka is full of domains nobody has instrumented:

  1. Agriculture — tea leaf grading, coconut yield, paddy disease. Decisions made daily by eye, recorded nowhere.
  2. Transport — actual bus and train arrival times versus published timetables. The gap is common knowledge and zero people have a dataset of it.
  3. Apparel QC — defect classification on factory floors, currently living in supervisors' heads.
  4. Public health — dengue case geography at a resolution finer than district-level reporting.
  5. Education — which A/L question types actually predict outcomes, versus which ones tuition classes claim do.

None of these have a clean public dataset. The absence is the opportunity, in exactly the way "skin usually dies in three days" was Outer's.

The expensive part of an AI product is rarely the inference. It is building the thing that generates ground truth. Pick a domain where generating ground truth is cheap for you and expensive for everyone else.


💰 What the same loop costs when it is software

Outer needed biobanks, IRB oversight, a wet lab near Cambridge, and 19 salaries to close its loop. If your domain is software-shaped, the same structure costs something closer to your weekends.

Loop component Outer Biosciences A software-shaped loop
Measurement apparatus Custom tissue support system A form, a scraper, or your app's own logs
Cost per label Lab time and consumables Near zero if users generate them
Iteration latency Weeks per experiment Minutes
Capital to start ~$23M raised Free tier
Who else has this data Nobody Nobody, if you picked well

The capital row cuts in your favour. For real numbers on the modelling side, our AI fine-tuning cost calculator and AI training compute calculator will tell you what a run actually costs on current provider pricing. For most small teams the answer is boring: compute is affordable, and data collection is the actual project.


⚠️ Read the pipeline numbers honestly

What Outer reports today: six active leads, several dozen additional hits logged, and an expectation that four of the six reach commercialisation. The business model is licensing or selling finished ingredients to beauty and pharma companies, plus revenue from research partnerships and consumer brand testing.

Note the tense. "Expected to reach commercialisation" is a forecast, not a result, and six leads is a small number to forecast from.

Warning: A tenfold speedup in candidate generation is not a tenfold speedup in candidates that work. Faster hypothesis generation is only valuable if your validation step stays honest, and the pressure on a fast loop is always to loosen the bar.

If you are building your own loop, this is the failure mode to design against. Hold out a real test set before you start, and know what your confidence interval looks like at your actual sample size — our train/test split calculator and confidence interval calculator cover both. A flywheel that spins fast on a contaminated evaluation is just an expensive way to fool yourself.


What this means for you

If you are an engineer, student, or two-person team here, take three things from this:

  1. Stop shopping for models. The frontier labs solved that layer. Your differentiation is upstream of it.
  2. Find a domain where you can generate ground truth and others cannot. Local access, local language, local relationships, a factory floor you can walk onto. Those are moats. A prompt is not.
  3. Build the measurement before the model. Outer spent years on tissue viability before the AI mattered. Your equivalent might be a scraper, a WhatsApp intake form, or a hundred hours of manual labelling. Do it anyway.

The headline says AI trained on living skin. The real story is a small team beating a hard problem by owning the experiment. That version costs far less than $23 million.

#ai#startups#data-strategy
IA

Induwara Ashinsana

Information Systems student at UCSC and Executive Director at Ryzera Technologies. Writes about software, AI, and what it means for builders in Sri Lanka.

About the author →

Keep reading